Literature DB >> 25136134

History of vaccination.

Stanley Plotkin1.   

Abstract

Vaccines have a history that started late in the 18th century. From the late 19th century, vaccines could be developed in the laboratory. However, in the 20th century, it became possible to develop vaccines based on immunologic markers. In the 21st century, molecular biology permits vaccine development that was not possible before.

Keywords:  genetic engineering; killed vaccines; live vaccine; proteins

Mesh:

Substances:

Year:  2014        PMID: 25136134      PMCID: PMC4151719          DOI: 10.1073/pnas.1400472111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  63 in total

1.  Nomenclature for immune correlates of protection after vaccination.

Authors:  Stanley A Plotkin; Peter B Gilbert
Journal:  Clin Infect Dis       Date:  2012-03-20       Impact factor: 9.079

2.  Immune responses in human volunteers upon oral administration of a rodent-adapted strain of poliomyelitis virus.

Authors:  H KOPROWSKI; G A JERVIS; T W NORTON
Journal:  Am J Hyg       Date:  1952-01

Review 3.  The new pentavalent rotavirus vaccine composed of bovine (strain WC3) -human rotavirus reassortants.

Authors:  H Fred Clark; Paul A Offit; Stanley A Plotkin; Penny M Heaton
Journal:  Pediatr Infect Dis J       Date:  2006-07       Impact factor: 2.129

4.  Isolation and characterization of Gal E mutant Ty 21a of Salmonella typhi: a candidate strain for a live, oral typhoid vaccine.

Authors:  R Germanier; E Füer
Journal:  J Infect Dis       Date:  1975-05       Impact factor: 5.226

Review 5.  Systems biological approaches to measure and understand vaccine immunity in humans.

Authors:  Shuzhao Li; Helder I Nakaya; Dmitri A Kazmin; Jason Z Oh; Bali Pulendran
Journal:  Semin Immunol       Date:  2013-06-21       Impact factor: 11.130

6.  An inactivated hepatitis A viral vaccine of cell culture origin.

Authors:  P J Provost; J V Hughes; W J Miller; P A Giesa; F S Banker; E A Emini
Journal:  J Med Virol       Date:  1986-05       Impact factor: 2.327

7.  Study of antirabies immunization of man; observations with HEP Flury and other vaccines, with and without hyperimmune serum, in primary and recall immunizations.

Authors:  J P FOX; H KOPROWSKI; D P CONWELL; J BLACK; H M GELFAND
Journal:  Bull World Health Organ       Date:  1957       Impact factor: 9.408

8.  Immunization of humans with polyribophosphate, the capsular antigen of Hemophilus influenzae, type b.

Authors:  P Anderson; G Peter; R B Johnston; L H Wetterlow; D H Smith
Journal:  J Clin Invest       Date:  1972-01       Impact factor: 14.808

9.  CHEMO-IMMUNOLOGICAL STUDIES ON CONJUGATED CARBOHYDRATE-PROTEINS : II. IMMUNOLOGICAL SPECIFICITY OF SYNTHETIC SUGAR-PROTEIN ANTIGENS.

Authors:  O T Avery; W F Goebel
Journal:  J Exp Med       Date:  1929-09-30       Impact factor: 14.307

10.  Human immunity to the meningococcus. 3. Preparation and immunochemical properties of the group A, group B, and group C meningococcal polysaccharides.

Authors:  E C Gotschlich; T Y Liu; M S Artenstein
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307

View more
  155 in total

1.  Assessing sequence plasticity of a virus-like nanoparticle by evolution toward a versatile scaffold for vaccines and drug delivery.

Authors:  Yuan Lu; Wei Chan; Benjamin Y Ko; Christopher C VanLang; James R Swartz
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-21       Impact factor: 11.205

2.  Novel antigen delivery systems.

Authors:  Maria Trovato; Piergiuseppe De Berardinis
Journal:  World J Virol       Date:  2015-08-12

3.  Lack of broad functional differences in immunity in fully vaccinated vs. unvaccinated children.

Authors:  Ashley M Sherrid; Candice E Ruck; Darren Sutherland; Bing Cai; Tobias R Kollmann
Journal:  Pediatr Res       Date:  2016-12-26       Impact factor: 3.756

Review 4.  Vaccine Design Informed by Virus-Induced Immunity.

Authors:  Rhiannon R Penkert; Jane S Hankins; Neal S Young; Julia L Hurwitz
Journal:  Viral Immunol       Date:  2020-05-05       Impact factor: 2.257

Review 5.  Vaccines, new opportunities for a new society.

Authors:  Rino Rappuoli; Mariagrazia Pizza; Giuseppe Del Giudice; Ennio De Gregorio
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-18       Impact factor: 11.205

6.  Vaccines: science, health, longevity, and wealth.

Authors:  Rino Rappuoli
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-26       Impact factor: 11.205

Review 7.  Life-Threatening Infections Due to Live-Attenuated Vaccines: Early Manifestations of Inborn Errors of Immunity.

Authors:  Laura Pöyhönen; Jacinta Bustamante; Jean-Laurent Casanova; Emmanuelle Jouanguy; Qian Zhang
Journal:  J Clin Immunol       Date:  2019-05-23       Impact factor: 8.317

Review 8.  The evolution of nasal immune systems in vertebrates.

Authors:  Ali Sepahi; Irene Salinas
Journal:  Mol Immunol       Date:  2015-09-19       Impact factor: 4.407

9.  Impact of Protein Glycosylation on the Design of Viral Vaccines.

Authors:  Kathleen Schön; Bernd Lepenies; Guillaume Goyette-Desjardins
Journal:  Adv Biochem Eng Biotechnol       Date:  2021       Impact factor: 2.635

10.  Serial Passaging of the Human Rotavirus CDC-9 Strain in Cell Culture Leads to Attenuation: Characterization from In Vitro and In Vivo Studies.

Authors:  Theresa Kathrina Resch; Yuhuan Wang; Sungsil Moon; Baoming Jiang
Journal:  J Virol       Date:  2020-07-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.